Ketazed (Ketotifen Hydrogen Fumarate)

Ketotifen hydrogen fumarate stabilises mast cells, preventing them from releasing histamine and other inflammatory mediators. It also blocks histamine H1 receptors on ocular tissues. By limiting both the release and the action of histamine, the drug reduces the allergic response in the eye.

The dosing regimen for Ketazed is determined by the prescribing clinician based on the severity of the allergic eye condition and the patient’s age. Typically, one or two drops are instilled in the affected eye(s) as directed, but the exact schedule should follow the healthcare professional’s instructions.

Safety data for ketotifen hydrogen fumarate in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Ketazed.

To order Ketazed, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketazed combines mast‑cell stabilisation with H1‑receptor blockade, offering both preventive and symptomatic relief. Some alternatives provide only antihistamine activity, which may relieve itching but not prevent mediator release. The dual mechanism of ketotifen can give broader control of allergic eye symptoms.

Ketazed should be stored at room temperature, below 25 °C, in its original container. Keep the bottle tightly closed, protect it from direct sunlight and moisture, and avoid freezing. Do not use the product if the solution appears discoloured or if the container is damaged.

Ketazed is applied as an eye drop. The patient should wash hands, tilt the head back, pull down the lower eyelid to create a small pocket, and place the prescribed number of drops into the conjunctival sac. Close the eye gently and avoid blinking excessively for a few seconds.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, significant eye pain, sudden vision loss, corneal ulceration, or acute angle‑closure glaucoma. Any of these symptoms require immediate medical attention and discontinuation of the product.

Ketazed should not be used by individuals with a known hypersensitivity to ketotifen hydrogen fumarate or any excipients in the formulation. It is also contraindicated in eyes with active infection, corneal ulceration, or in patients with narrow‑angle glaucoma unless specifically advised by an eye‑care professional.